Berberine-loaded Janus gold mesoporous silica nanocarriers for chemo/radio/photothermal therapy of liver cancer and radiation-induced injury inhibition

References

• Maluccio MM, Covey AM. Recent progress in understanding, diagnosing, and treating hepatocellular carcinoma. CA Cancer J Clin. 2012;62(6):394–399. doi:10.3322/caac.2116123070690
   PubMed Web of Science ®Google Scholar
• Yang JD, Roberts LR. Hepatocellular carcinoma: a global view. Nature Rev Gastroenterol Hepatol. 2010;7(8):448–458. doi:10.1038/nrgastro.2010.10020628345
   PubMed Web of Science ®Google Scholar
• Bruix J, Gores GJ, Mazzaferro V. Hepatocellular carcinoma: clinical frontiers and perspectives. Gut. 2014;63(5):844–855. doi:10.1136/gutjnl-2013-30662724531850
   PubMed Web of Science ®Google Scholar
• Cheng JC, Chuang VP, Cheng SH, et al. Local radiotherapy with or without transcatheter arterial chemoembolization for patients with unresectable hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2000;47(2):435–442. doi:10.1016/S0360-3016(00)00462-410802371
   PubMedGoogle Scholar
• Chen SW, Lin LC, Kuo YC, Liang JA, Kuo CC, Chiou JF. Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma. Int J Radiat Oncol Biol Phys. 2014;88(5):1041–1047. doi:10.1016/j.ijrobp.2014.01.01724661657
   PubMed Web of Science ®Google Scholar
• Knox JJ, Cleary SP, Dawson LA. Localized and systemic approaches to treating hepatocellular carcinoma. J Clin Oncol. 2015;33(16):1835–1844. doi:10.1200/JCO.2014.60.115325918289
   PubMedGoogle Scholar
• Chu KF, Dupuy DE. Thermal ablation of tumours: biological mechanisms and advances in therapy. Nature Rev Cancer. 2014;14(3):199–208. doi:10.1038/nrc367224561446
   PubMed Web of Science ®Google Scholar
• Hwang J, Chan D, Chang T, et al. Effects of oral arginine and glutamine on radiation-induced injury in the rat. J Surg Res. 2003;109(2):149–154.12643857
   PubMed Web of Science ®Google Scholar
• Hauerjensen M, Wang J, Boerma M, Fu Q, Denham JW. Radiation damage to the gastrointestinal tract: mechanisms, diagnosis, and management. Curr Opin Support Palliat Care. 2007;1(1):23–29. doi:10.1097/SPC.0b013e328110801418660720
   PubMedGoogle Scholar
• Cheng A, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10(1):25–34. doi:10.1016/S1470-2045(08)70285-719095497
   PubMed Web of Science ®Google Scholar
• Gish RG, Porta C, Lazar L, et al. Phase III randomized controlled trial comparing the survival of patients with unresectable hepatocellular carcinoma treated with nolatrexed or doxorubicin. J Clin Oncol. 2007;25(21):3069–3075. doi:10.1200/JCO.2006.08.404617634485
   PubMed Web of Science ®Google Scholar
• Kraus A, Ferber I, Bachmann S, et al. In vitro chemo- and radio-resistance in small cell lung cancer correlates with cell adhesion and constitutive activation of AKT and MAP kinase pathways. Oncogene. 2002;21(57):8683–8695. doi:10.1038/sj.onc.120593912483521
   PubMedGoogle Scholar
• Fukuda K, Hibiya Y, Mutoh M, Koshiji M, Akao S, Fujiwara H. Inhibition by berberine of cyclooxygenase-2 transcriptional activity in human colon cancer cells. J Ethnopharmacol. 1999;66(2):227–233.10433483
   PubMed Web of Science ®Google Scholar
• Yue J, Wang Z, Shao D, et al. Cancer cell membrane-modified biodegradable mesoporous silica nanocarriers for berberine therapy of liver cancer. RSC Adv. 2018;8(70):40288–40297. doi:10.1039/C8RA07574C
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Y, Chang Z, et al. Berberine-loaded Janus nanocarriers for magnetic field-enhanced therapy against hepatocellular carcinoma. Chem Biol Drug Des. 2017;89(3):464–469. doi:10.1111/cbdd.1286627618577
   PubMed Web of Science ®Google Scholar
• Li G, Wang D, Hu Y, et al. Berberine inhibits acute radiation intestinal syndrome in human with abdomen radiotherapy. Med Oncol. 2010;27(3):919–925. doi:10.1007/s12032-009-9307-819757213
   PubMedGoogle Scholar
• Yang X, Yang B, Cai J, et al. Berberine enhances radiosensitivity of esophageal squamous cancer by targeting HIF-1α in vitro and in vivo. Cancer Biol Ther. 2013;14(11):1068–1073. doi:10.4161/cbt.2642624025355
   PubMed Web of Science ®Google Scholar
• Tan W, Li Y, Chen M, Wang Y. Berberine hydrochloride: anticancer activity and nanoparticulate delivery system. Int J Nanomedicine. 2011;6:1773–1777. doi:10.2147/IJN.S2268321931477
   PubMedGoogle Scholar
• Kumar A, Ekavali CK, Mukherjee M, Pottabathini R, Dhull DK. Current knowledge and pharmacological profile of berberine: an update. Eur J Pharmacol. 2015;761:288–297. doi:10.1016/j.ejphar.2015.05.06826092760
   PubMed Web of Science ®Google Scholar
• Pund S, Borade G, Rasve G. Improvement of anti-inflammatory and anti-angiogenic activity of berberine by novel rapid dissolving nanoemulsifying technique. Phytomedicine. 2014;21(3):307–314. doi:10.1016/j.phymed.2013.09.01324176841
   PubMed Web of Science ®Google Scholar
• Hainfeld JF, Dilmanian FA, Slatkin DN, Smilowitz HM. Radiotherapy enhancement with gold nanoparticles. J Pharm Pharmacol. 2008;60(8):977–985. doi:10.1211/jpp.60.8.000518644191
   PubMed Web of Science ®Google Scholar
• Roa W, Zhang X, Guo L, et al. Gold nanoparticle sensitize radiotherapy of prostate cancer cells by regulation of the cell cycle. Nanotechnology. 2009;20(37):375101. doi:10.1088/0957-4484/20/37/37510119706948
   PubMed Web of Science ®Google Scholar
• Her S, Jaffray DA, Allen C. Gold nanoparticles for applications in cancer radiotherapy: mechanisms and recent advancements. Adv Drug Deliv Rev. 2017;109:84–101. doi:10.1016/j.addr.2015.12.01226712711
   PubMed Web of Science ®Google Scholar
• Zhou M, Zhao J, Tian M, et al. Radio-photothermal therapy mediated by a single compartment nanoplatform depletes tumor initiating cells and reduces lung metastasis in the orthotopic 4T1 breast tumor model. Nanoscale. 2015;7(46):19438–19447. doi:10.1039/c5nr04587h26376843
   PubMedGoogle Scholar
• Banu H, Sethi DK, Edgar A, et al. Doxorubicin loaded polymeric gold nanoparticles targeted to human folate receptor upon laser photothermal therapy potentiates chemotherapy in breast cancer cell lines. J Photochem Photobiol B-Biol. 2015;149:116–128. doi:10.1016/j.jphotobiol.2015.05.008
   PubMed Web of Science ®Google Scholar
• Hu R, Zheng M, Wu J, et al. Core-shell magnetic gold nanoparticles for magnetic field-enhanced radio-photothermal therapy in cervical cancer. Nanomaterials. 2017;7(5):111. doi:10.3390/nano7120458
   Web of Science ®Google Scholar
• Wang Z, Chang Z, Lu M, et al. Janus silver/silica nanoplatforms for light-activated liver cancer chemo/photothermal therapy. ACS Appl Mater Interfaces. 2017;9(36):30306–30317. doi:10.1021/acsami.7b0644628836433
   PubMedGoogle Scholar
• Shao D, Li M, Wang Z, et al. Bioinspired diselenide-bridged mes-oporous silica nanoparticles for dual-responsive protein delivery. Adv Mater 2018;30:1801198.
   Google Scholar
• Shakerizadeh A, Shiran M, Khoee S, Sharifi AM, Ghaznavi H, Khoei S. A new magnetic nanocapsule containing 5-fluorouracil: in vivo drug release, anti-tumor, and pro-apoptotic effects on CT26 cells allograft model. J Biomater Appl. 2014;29(4):548–556. doi:10.1177/088532821453694024913615
   PubMedGoogle Scholar
• Shakerizadeh A, Khoee S, Shiran M, Sharifi AM, Khoei S. Synergistic effects of magnetic drug targeting using a newly developed nanocapsule and tumor irradiation by ultrasound on CT26 tumors in BALB/c mice. J Mater Chem B. 2015;3(9):1879–1887. doi:10.1039/C4TB01708K
   PubMed Web of Science ®Google Scholar
• Keshavarz M, Moloudi K, Paydar R, et al. Alginate hydrogel co-loaded with cisplatin and gold nanoparticles for computed tomography image-guided chemotherapy. J Biomater Appl. 2018;33(2):161–169. doi:10.1177/088532821878235529933708
   PubMed Web of Science ®Google Scholar
• Alamzadeh Z, Beik J, Mahabadi VP, et al. Ultrastructural and optical characteristics of cancer cells treated by a nanotechnology based chemo-photothermal therapy method. J Photochem Photobiol B-Biol. 2019;192:19–25. doi:10.1016/j.jphotobiol.2019.01.005
   PubMed Web of Science ®Google Scholar
• Beik J, Jafariyan M, Montazerabadi A, et al. The benefits of folic acid-modified gold nanoparticles in CT-based molecular imaging: radiation dose reduction and image contrast enhancement. Artif Cells Nanomed Biotechnol. 2017;46(8):1993–2001.29233015
   PubMed Web of Science ®Google Scholar
• Zhang Z, Wang L, Wang J, et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mat. 2012;24(11):1418–1423. doi:10.1002/adma.201104714
   PubMed Web of Science ®Google Scholar
• Liu R, Zhang Y, Zhao X, Agarwal A, Mueller LJ, Feng P. pH-responsive nanogated ensemble based on gold-capped mesoporous silica through an acid-labile acetal linker. J Am Chem Soc. 2010;132(5):1500–1501. doi:10.1021/ja907838s20085351
   PubMedGoogle Scholar
• Viveroescoto JL, Slowing II, Wu C, Lin VSY. Photoinduced intracellular controlled release drug delivery in human cells by gold-capped mesoporous silica nanosphere. J Am Chem Soc. 2009;131(10):3462–3463. doi:10.1021/ja900025f19275256
   PubMedGoogle Scholar
• Wang Z, Shao D, Chang Z, et al. Janus gold nanoplatform for synergetic chemoradiotherapy and computed tomography imaging of hepatocellular carcinoma. ACS Nano. 2017;11(12):12732–12741. doi:10.1021/acsnano.7b0748629140684
   PubMed Web of Science ®Google Scholar
• Wang Z, Wang Y, Lu M, et al. Janus Au–mesoporous silica nanocarriers for chemo-photothermal treatment of liver cancer cells. RSC Adv. 2016;6(50):44498–44505. doi:10.1039/C6RA04183C
   Web of Science ®Google Scholar
• Neshastehriz A, Tabei M, Maleki S, Eynali S, Shakeri-Zadeh A. Photothermal therapy using folate conjugated gold nanoparticles enhances the effects of 6 MV X-ray on mouth epidermal carcinoma cells. J Photochem Photobiol B. 2017;172:52–60. doi:10.1016/j.jphotobiol.2017.05.01228527427
   PubMed Web of Science ®Google Scholar
• Ghaznavi H, Hosseini-Nami S, Kamrava SK, et al. Folic acid conjugated PEG coated gold–iron oxide core–shell nanocomplex as a potential agent for targeted photothermal therapy of cancer. Artif Cells Nanomed Biotechnol. 2018;46(8):1594–1604. doi:10.1080/21691401.2017.138438428994325
   PubMed Web of Science ®Google Scholar
• Beik J, Khademi S, Attaran N, et al. A nanotechnology-based strategy to increase the efficiency of cancer diagnosis and therapy: folate-conjugated gold nanoparticles. Curr Med Chem. 2017;24(39):4399–4416. doi:10.2174/092986732466617081015491728799495
   PubMed Web of Science ®Google Scholar
• Mirrahimi M, Hosseini V, Kamrava SK, et al. Selective heat generation in cancer cells using a combination of 808 nm laser irradiation and the folate-conjugated Fe2O3@ Au nanocomplex. Artif Cells Nanomed Biotechnol. 2018;46(sup1):241–253. doi:10.1080/21691401.2017.1420072
   PubMed Web of Science ®Google Scholar
• Montazerabadi A, Beik J, Irajirad R, et al. Folate-modified and curcumin-loaded dendritic magnetite nanocarriers for the targeted thermo-chemotherapy of cancer cells. Artif Cells Nanomed Biotechnol. 2019;47(1):330–340. doi:10.1080/21691401.2018.155767030688084
   PubMed Web of Science ®Google Scholar
• Wang Y, Shao D, Zhang L, et al. Gold nanorods-silica Janus nanoparticles for theranostics. Appl Phys Lett. 2015;106(17):173705. doi:10.1063/1.4919454
   Web of Science ®Google Scholar
• Wu Q, Yang Z, Nie Y, Shi Y, Fan D. Multi-drug resistance in cancer chemotherapeutics: mechanisms and lab approaches. Cancer Lett. 2014;347(2):159–166. doi:10.1016/j.canlet.2014.03.01324657660
   PubMed Web of Science ®Google Scholar
• Mi Y, Lou L. ZD6474 reverses multidrug resistance by directly inhibiting the function of P-glycoprotein. Br J Cancer. 2007;97(7):934. doi:10.1038/sj.bjc.660398517912240
   PubMed Web of Science ®Google Scholar
• Kvols LK. Radiation sensitizers: a selective review of molecules targeting DNA and non-DNA targets. J Nucl Med. 2005;46(1):187S.15653668
   PubMedGoogle Scholar
• Lu Q-B. Molecular reaction mechanisms of combination treatments of low-dose cisplatin with radiotherapy and photodynamic therapy. J Med Chem. 2007;50(11):2601–2604. doi:10.1021/jm061416b17474733
   PubMedGoogle Scholar
• Mirrahimi M, Khateri M, Beik J, et al. Enhancement of chemoradiation by co-incorporation of gold nanoparticles and cisplatin into alginate hydrogel. J Biomed Mat Res Part B. 2019. doi:10.1002/jbm.b.34356
   PubMed Web of Science ®Google Scholar
• Kumar R, Belz J, Markovic S, et al. Nanoparticle-based brachytherapy spacers for delivery of localized combined chemoradiation therapy. Int J Radiat Oncol Biol Phys. 2015;91(2):393–400. doi:10.1016/j.ijrobp.2014.10.04125636762
   PubMedGoogle Scholar
• Park J, Park J, Ju EJ, et al. Multifunctional hollow gold nanoparticles designed for triple combination therapy and CT imaging. J Controlled Release. 2015;207:77–85. doi:10.1016/j.jconrel.2015.04.007
   PubMed Web of Science ®Google Scholar
• Li G, Zhang Y, Tang J, et al. Effects of berberine against radiation-induced intestinal injury in mice. Int J Radiat Oncol Biol Phys. 2010;77(5):1536–1544. doi:10.1016/j.ijrobp.2010.02.06220637981
   PubMedGoogle Scholar
• Gu L, Li N, Yu W, et al. Berberine reduces rat intestinal tight junction injury induced by ischemia-reperfusion associated with the suppression of inducible nitric oxide synthesis. Am J Chin Med (Gard City NY). 2013;41(6):1297–1312. doi:10.1142/S0192415X13500870
   PubMed Web of Science ®Google Scholar